The numbers on nicotine pouches are scattered across government surveys, paywalled journals, tobacco company earnings calls, and press releases that quietly contradict each other. This page pulls them into one place. Every statistic links to its primary source: a federal survey, a peer-reviewed study, an SEC filing, or an official agency announcement. No retailer blogs, no recycled listicles.
Two things worth knowing about who's behind this. First, this site sells nothing and takes no money from anyone who profits from nicotine, in either direction. Second, the whole site exists to help people quit pouches, so the framing is honest about that. The numbers themselves don't need any spin.
Each stat has its own anchor link (the # symbol next to the source) so you can link directly to a specific number. The page is updated by hand every month; the date at the top is real.
The key numbers
Growth in US monthly nicotine pouch sales from January 2023 ($145.5M) to August 2025 ($510.5M)
Cans of ZYN shipped in the US in 2025, up 37% in a single year
US middle and high school students currently using nicotine pouches (2025)
Young adult nicotine users who plan to quit in 2026
Sales and market growth
Nicotine pouches are the fastest-growing tobacco category in the United States, and it isn't close. The clearest data series comes from the CDC Foundation, which tracks retail point-of-sale data collected by Circana across US outlets.
US monthly pouch sales grew 251% in two and a half years
Monthly US retail sales of nicotine pouches rose from $145.5 million in the four-week period ending January 29, 2023 to $510.5 million in the period ending August 10, 2025. That is a 250.8% increase.
Source: CDC Foundation, Monitoring Sales data brief (Circana retail data), 2025 · #
ZYN shipped 794 million US cans in 2025
Philip Morris International shipped 794 million cans of ZYN in the US in 2025, up 37% from 2024. In the second quarter of 2026 alone, US shipments reached 2.9 billion pouches, and ZYN is now sold in 60 markets worldwide.
Sources: PMI full-year 2025 results; PMI Q2 2026 earnings (SEC filing) · #
The global market passed 23 billion pouches and $7 billion
Global retail sales exceeded 23 billion pouch units in 2024, up more than 50% in one year. The World Health Organization put the global market's value at nearly 7 billion US dollars in 2025.
Source: WHO, first global report on nicotine pouches, 2026 · #
| Flavor category | Share of US pouch sales (Aug 2025) |
|---|---|
| Mint | 60.5% |
| Fruit, candy, and drink flavors | 23.6% |
| "Smooth" or "original" (typically sweetened) | 10.5% |
| Tobacco flavor | 0.1% |
Source: CDC Foundation, Monitoring Sales data brief, 2025 · #
Sit with that last row for a second. A product line descended from tobacco sells almost nothing that tastes like tobacco. The flavors doing the selling are mint and candy, which matters when you get to the youth numbers below.
How many adults use nicotine pouches
Adult use is still a single-digit percentage, but it is climbing fast, and it concentrates heavily in young adults and men.
Adult past-month use nearly doubled in one year
Among US adults aged 19 to 65, past-30-day nicotine pouch use rose from 2.3% in 2023 to 4.2% in 2024. Past-year use rose from 3.4% to 5.9% over the same period.
Source: Monitoring the Future panel study, American Journal of Preventive Medicine, 2024 data · #
Young adults are the heaviest users: 9.5%
Adults aged 19 to 30 reported 9.5% past-year pouch use in 2024, the highest of any adult age group. If you're in that bracket and reading this site, you are the market these products are built for.
Source: Monitoring the Future panel study, 2024 data · #
Use skews heavily male
Among US youth, girls' lifetime pouch use runs at roughly a third of boys' (risk ratio 0.37). In Great Britain, 1.57% of men currently use pouches versus 0.40% of women.
Sources: JAMA Network Open, 2024; ASH Smokefree GB surveys, Nicotine & Tobacco Research, 2024 · #
Sweden: 22% of men use snus daily, and smoking has nearly vanished
In Sweden, where pouches descend from a long snus tradition, 22% of men aged 16 to 84 used snus daily in 2024. In 2025 Sweden's daily smoking rate fell to 4.8%, below the 5% threshold for a "smoke-free" country, while roughly a quarter of the population still uses nicotine daily in some form. Smoking left; the addiction stayed.
Sources: Public Health Agency of Sweden, 2024; CAN survey via AFP, 2025 · #
Great Britain: adult use doubled since 2020
Current pouch use among GB adults doubled from 0.5% in 2020 to 1.0% in 2024, with 5.4% having ever tried them. Among 11 to 18 year olds, 1.2% currently use pouches.
Source: ASH Smokefree GB surveys, Nicotine & Tobacco Research, 2020-2024 · #
If you're comparing formats rather than countries, the honest side-by-side of pouches against vaping, including who tends to use each and why switching between them rarely helps, is in the nicotine pouches vs vaping comparison.
Teen and youth use
Two big federal surveys track teen use, and they currently tell slightly different stories. The National Youth Tobacco Survey shows use holding roughly flat at a high level, while Monitoring the Future and a JAMA analysis show it doubling among older teens. Both agree on the ranking: pouches are now the second most common tobacco product among American youth, behind e-cigarettes.
About 460,000 US students currently use pouches
The 2025 National Youth Tobacco Survey found 1.7% of all middle and high school students currently use nicotine pouches: 2.3% of high schoolers (about 350,000) and 0.9% of middle schoolers (about 100,000). In 2024 the figure was 1.8%, with 890,000 students having ever used them.
Sources: 2025 NYTS, Nicotine & Tobacco Research; 2024 NYTS, CDC MMWR · #
Use doubled among 10th and 12th graders in one year
Past-30-day pouch use among 10th and 12th graders rose from 1.3% (about 94,000 students) in 2023 to 2.6% (about 192,000) in 2024.
Source: Han, Harlow et al., JAMA Network Open, 2025 · #
9 in 10 teen users choose flavored pouches
90.8% of youth current pouch users used a flavored product in 2025, and 26.3% used pouches on 20 or more days per month. In 2024, 22.4% of teen users used them daily. This is not experimentation; for a quarter of teen users it's already a habit.
Sources: 2025 NYTS; 2024 NYTS, CDC MMWR · #
Which brands teens actually use, from the 2024 NYTS:
| Brand | Share of youth current pouch users naming it |
|---|---|
| ZYN | 68.7% |
| on! | 14.2% |
| Rogue | 13.6% |
| VELO | 10.7% |
| Juice Head ZTN | 9.8% |
Source: 2024 NYTS, CDC MMWR (students could name multiple brands) · #
Viral TikTok spikes were followed by 12-million-unit sales jumps
A Truth Initiative analysis of more than 10,000 pouch-related TikTok videos posted between January 2021 and October 2023, which drew over 71 million views combined, found a reciprocal relationship between viral spikes and retail sales: one viral surge was followed by a sales jump of more than 12 million units the next month. 68% of US teens use TikTok.
Source: Truth Initiative study in Tobacco Control, 2026 · #
If the teen in question is yours, the numbers stop being abstract fast. There's a dedicated guide for parents on helping a teenager quit ZYN, and one written for teens themselves on quitting as a teenager.
Addiction and quitting
The addiction numbers are the reason this site exists, so here they are without decoration.
67% of young adult nicotine users plan to quit in 2026
Two thirds of young adult nicotine users say they plan to quit this year, citing physical and mental health as their top reasons. Nearly one million people aged 13 to 24 have enrolled in Truth Initiative's free EX quit program, with 2,000 to 3,000 more joining every week.
Source: Truth Initiative, EX Program announcement, 2026 · #
Only 3-5% of unaided quit attempts last
The classic research on unaided quitting found that only 3 to 5% of attempts reach 6 to 12 months of abstinence, and most relapse happens within the first 8 days. The figure comes from smoking research, the long-standing benchmark for nicotine, since pouch-specific quit data doesn't exist yet. The fix isn't more willpower; it's preparation. See cold turkey vs tapering for what actually improves the odds.
Source: Hughes, Keely & Naud, Addiction, 2004 · #
How much nicotine is actually in these products:
| Product | Nicotine per pouch |
|---|---|
| ZYN (US, FDA-authorized) | 3mg and 6mg |
| ZYN Ultra (US, authorized Aug 2026) | 9mg and 11mg |
| on! | 2mg to 8mg |
| International brands (44 tested by German BfR) | 1.79mg up to 47.5mg |
Sources: FDA authorizations, 2025-2026; BfR analysis via Frontiers in Public Health review, 2025 · #
A strong pouch delivers more nicotine than a cigarette
In clinical testing, a 30mg pouch produced nearly double a cigarette's peak blood nicotine concentration (29.4 vs 15.2 ng/mL) and about twice the total nicotine exposure. Anyone who has climbed the strength ladder from 3mg to "whatever gets me through a meeting" already knows this in their body.
Source: Frontiers in Pharmacology, 2024 · #
If those numbers describe your tin, the practical way out is covered step by step in the complete guide to quitting nicotine pouches, and the research on quit aids, which roughly triple success rates when combined with counseling, is in the medications and NRT overview. What withdrawal feels like week by week is mapped in the nicotine withdrawal timeline.
What the health research shows
Here's the honest version, including the part most stats pages skip: nicotine pouches are too new for anyone to know their long-term effects. They have only been mass-marketed since around 2016, and ZYN went national in the US in 2019. There is no long-term epidemiological data on cancer or cardiovascular outcomes yet. Anyone claiming certainty in either direction is ahead of the evidence. What exists so far:
Strong pouches raise heart rate almost as much as cigarettes
In clinical measurements, 20mg pouches raised heart rate by about 12 beats per minute and 30mg pouches by about 25, close to a cigarette's 27. Markers of arterial stiffness were significantly elevated with high-dose pouches.
Source: Frontiers in Pharmacology, 2024 · #
Gum damage at the pouch site is showing up in case reports
Published clinical case reports document gum recession and leukoplakia (white pre-cancerous patches) exactly where the pouch sits, including in a 22-year-old after 11 months of daily use. Gum recession does not reverse on its own; the details are in the guide on whether gums grow back after quitting.
Source: BMC Oral Health, 2025 · #
Child poisonings from pouches rose 763% in three years
Nicotine pouch ingestions among children under 6 rose 763% between 2020 and 2023. Across 134,663 pediatric nicotine ingestions from 2010 to 2023, three quarters involved children under 2, with 39 major medical outcomes and 2 deaths. Pouches were more likely than other nicotine products to cause serious outcomes or hospitalization. The tins are flavored, colorful, and live in pockets and cup holders.
Source: Pediatrics (National Poison Data System study), 2025 · #
FDA authorization means "lower risk than cigarettes," not "safe"
In January 2025 the FDA authorized 20 ZYN products, the first nicotine pouches ever authorized, finding the benefit to adult smokers who switch completely outweighed the youth risk. In June 2026 it went further, letting those products carry a modified-risk claim naming lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis compared with cigarettes. The CDC's position is unchanged: no tobacco product is safe, and nicotine is especially harmful for youth, young adults, and pregnant women. The full breakdown of what authorization does and doesn't mean is in is ZYN bad for you.
Sources: FDA, January 2025; FDA, June 2026; CDC, nicotine pouches · #
Regulation around the world
Regulation is a patchwork, and most of the world hasn't caught up to the product at all.
160 countries have no specific rules for nicotine pouches
Per the WHO's first global report on pouches, 160 states have no framework governing their sale, only 32 countries or territories actively regulate them, and 16 have banned sales outright, including Belgium (2023), the Netherlands (2025), and France.
Source: WHO global report, 2026 · #
Where the big regulators stand as of August 2026:
| Jurisdiction | Status |
|---|---|
| United States | Legal, minimum age 21; 43 products FDA-authorized as of Aug 2026; California and Massachusetts ban flavored sales |
| United Kingdom | Tobacco and Vapes Act 2026 makes under-18 sales illegal from Oct 29, 2026 (previously no minimum age applied to pouches) |
| European Union | Not covered by current EU tobacco rules; revision proposal expected Dec 2026 |
| Belgium, Netherlands, France | Sales banned |
| Sweden | Legal, long-established snus and pouch market |
Sources: FDA; UK Tobacco and Vapes Act 2026; European Commission consultation coverage; WHO · #
After California's cooling-flavor ban, "smooth" sales rose 150%
When California explicitly banned cooling-sensation products from January 1, 2025, cooling-flavor pouch sales in the state fell 97.8% by August 2025, while "smooth" and "original" sales rose 150% over the same window. The category adapts to regulation faster than regulation adapts to the category.
Source: CDC Foundation, Monitoring Sales data brief, 2025 · #
This month in nicotine
A hand-picked digest of what actually mattered in the pouch world recently. No feed, no algorithm; curated by a human once a month.
The FDA authorized 11 ZYN Ultra products at 9mg and 11mg, the strongest ZYN ever legal in the US. The strength ceiling for authorized pouches nearly doubled in one decision. FDA announcement
The FDA authorized 4 new on! pouches under its pilot review program, while physicians publicly warned that "lower-risk" marketing is reaching people who never smoked. FDA announcement; NPR coverage
The EU's public consultation on rewriting its tobacco rules closed. A legislative proposal expected in December 2026 would regulate pouches EU-wide for the first time. Euronews coverage
Philip Morris reported its first quarter above $11 billion in revenue, with 2.9 billion ZYN pouches shipped in the US in Q2 and the ZYN Ultra rollout beginning. SEC filing
The FDA granted first-ever modified-risk orders to 20 ZYN products, allowing them to be marketed as lower risk than cigarettes. Public health critics warned the claim will be read as "safe." FDA announcement
Using these statistics
Every number on this page traces to a primary source: a federal survey, a peer-reviewed journal, an SEC filing, or an official agency release. Click any source link to check the original. Where a figure has a real limitation (like the 3-5% quit rate coming from smoking research), the limitation is stated next to the number instead of hidden.
If you're a journalist, researcher, or writer, you're welcome to use anything here. Cite the primary source for the number itself, and if this page saved you the digging, a link to it helps other people find the originals too. Each stat's # symbol gives you a direct anchor link to that specific figure.
Spotted a newer figure or an error? Email privacy@quitsnus.com and it will be checked against the source and fixed in the next monthly update.
And if you landed here because the numbers describe you rather than your research: the practical exit starts with the free step-by-step quit plan, and the honest picture of what the industry doesn't say is on the facts page.
Frequently asked questions
How many people use nicotine pouches in the US?
About 4.2% of US adults aged 19 to 65 used nicotine pouches in the past 30 days in 2024, up from 2.3% in 2023, according to the Monitoring the Future panel study. Among students, the 2025 National Youth Tobacco Survey counted about 460,000 current users. Young adults aged 19 to 30 have the highest use of any adult age group at 9.5% in the past year.
What percentage of teens use nicotine pouches?
In the 2025 National Youth Tobacco Survey, 1.7% of US middle and high school students reported current nicotine pouch use, about 460,000 kids. Use among 10th and 12th graders doubled from 1.3% to 2.6% between 2023 and 2024. Nicotine pouches are now the second most common tobacco product among American youth, behind e-cigarettes.
Are nicotine pouch sales still growing?
Yes. US monthly retail sales grew from $145.5 million in January 2023 to $510.5 million in August 2025, a 251% increase. ZYN alone shipped 794 million cans in the US in 2025, 37% more than in 2024. The World Health Organization valued the global market at nearly $7 billion in 2025.
Are nicotine pouches FDA approved?
The FDA does not approve tobacco products; it authorizes them. As of August 2026 the FDA has authorized 43 nicotine pouch products, including ZYN and on!. Authorization means the agency judged them lower risk than cigarettes for adult smokers who switch completely. It is not a safety endorsement, and the FDA stresses that no tobacco or nicotine product is safe.
How much nicotine is in a nicotine pouch?
US-authorized pouches range from 2mg to 11mg of nicotine per pouch after the FDA authorized 9mg and 11mg ZYN Ultra in August 2026. Internationally, lab analyses have found pouches containing up to 47.5mg. Clinical testing shows a strong pouch can deliver more nicotine into the blood than a cigarette.
Get daily tips for your first 30 days
One email a day with practical strategies, encouragement, and real talk about what you're going through. Free, no spam, unsubscribe anytime.
No spam, ever. Just help quitting.